KMT2A rearranged B lineage infant ALL cell line SEM treated with bortezomib LC-MS/MS
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/pride/PXD038845
下载链接
链接失效反馈官方服务：
资源简介：
The KMT2A rearranged B lineage infant ALL cell line SEM was treated with the proteasome inhibitor bortezomib followed by a multiplexed mass spectrometry-based proteomic analysis at multiple time points (0, 6, 12, 16, and 20 hours) over 20 hours to further understand the cellular response of these cells to proteasome inhibition.
创建时间：
2023-02-15
